During the last session, Nu Skin Enterprises, Inc (NYSE:NUS)’s traded shares were 0.36 million, with the beta value of the company hitting 1.17. At the end of the trading day, the stock’s price was $6.89, reflecting an intraday loss of -3.50% or -$0.25. The 52-week high for the NUS share is $19.30, that puts it down -180.12 from that peak though still a striking 13.64% gain since the share price plummeted to a 52-week low of $5.95. The company’s market capitalization is $342.51M, and the average intraday trading volume over the past 10 days was 0.61 million shares, and the average trade volume was 808.19K shares over the past three months.
Nu Skin Enterprises, Inc (NYSE:NUS) trade information
Nu Skin Enterprises, Inc (NUS) registered a -3.50% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.50% in intraday trading to $6.89, hitting a weekly high. The stock’s 5-day price performance is -0.58%, and it has moved by 4.39% in 30 days. Based on these gigs, the overall price performance for the year is -62.33%. The short interest in Nu Skin Enterprises, Inc (NYSE:NUS) is 1.16 million shares and it means that shorts have 1.67 day(s) to cover.
The consensus price target of analysts on Wall Street is $11, which implies an increase of 37.36% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $11 and $11 respectively. As a result, NUS is trading at a discount of -59.65% off the target high and -59.65% off the low.
Nu Skin Enterprises, Inc (NUS) estimates and forecasts
Statistics show that Nu Skin Enterprises, Inc has underperformed its competitors in share price, compared to the industry in which it operates. Nu Skin Enterprises, Inc (NUS) shares have gone down -32.98% during the last six months, with a year-to-date growth rate less than the industry average at -63.24% against -4.90. In the rating firms’ projections, revenue will decrease -12.52% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 435.99M as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 399.8M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 488.64M and 417.31M respectively. In this case, analysts expect current quarter sales to shrink by -10.77% and then drop by -4.20% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -39.68%. While earnings are projected to return -63.50% in 2025, the next five years will return -6.46% per annum.
NUS Dividends
Nu Skin Enterprises, Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Nu Skin Enterprises, Inc is 0.24, with the dividend yield indicating at 3.48 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 4.8%.
Nu Skin Enterprises, Inc (NYSE:NUS)’s Major holders
Nu Skin Enterprises, Inc insiders own 2.29% of total outstanding shares while institutional holders control 79.90%, with the float percentage being 81.77%. BLACKROCK INC. is the largest shareholder of the company, while 281.0 institutions own stock in it. As of 2024-06-30, the company held over 8.12 million shares (or 16.3966% of all shares), a total value of $85.61 million in shares.
The next largest institutional holding, with 6.55 million shares, is of VANGUARD GROUP INC’s that is approximately 13.214% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $68.99 million.
Also, the Mutual Funds coming in first place with the largest holdings of Nu Skin Enterprises, Inc (NUS) shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 1.63 shares. This amounts to just over 3.28 percent of the company’s overall shares, with a $11.24 million market value. The same data shows that the other fund manager holds slightly less at 1.34, or about 2.69% of the stock, which is worth about $9.2 million.
